What is the current valuation of the US human milk-oligosaccharides market?

The market valuation was $121.8 Million in 2024. Read More

What is the projected market size for the US human milk-oligosaccharides market by 2035?

The market is projected to reach $528.76 Million by 2035. Read More

What is the expected CAGR for the US human milk-oligosaccharides market during the forecast period 2025 - 2035?

The expected CAGR is 14.28% during the forecast period. Read More

Which companies are the key players in the US human milk-oligosaccharides market?

Key players include Nestle (CH), Danone (FR), and FrieslandCampina (NL), among others. Read More

What are the main application segments in the US human milk-oligosaccharides market?

Main application segments include Infant Formula, Functional Foods, and Dietary Supplements. Read More

How did the Infant Formula segment perform in 2024?

The Infant Formula segment was valued between $40.0 Million and $180.0 Million in 2024. Read More

What is the valuation range for the Synthetic Production source segment?

The Synthetic Production source segment was valued between $50.0 Million and $250.0 Million in 2024. Read More

What forms of human milk-oligosaccharides are available in the market?

Available forms include Powder, Liquid, and Capsules. Read More

What was the market valuation for the Food and Beverages end-use segment in 2024?

The Food and Beverages end-use segment was valued between $45.72 Million and $200.0 Million in 2024. Read More

How does the market for human milk-oligosaccharides appear to be evolving?

The market appears to be growing rapidly, with a projected increase in valuation and a strong CAGR. Read More

US Human Milk Oligosaccharides Market

US Human Milk Oligosaccharides Market Size, Share, Industry Trend & Analysis Research Report: By Application (Infant Formula, Functional Foods, Dietary Supplements), By Source (Human Milk, Synthetic Production, Animal Milk), By Form (Powder, Liquid, Capsules) andBy End Use (Healthcare, Food and Beverages, Nutraceuticals)- Forecast to 2035

Forecast Period

2025 - 2035

CAGR

14.28%

2024 Market Size

$ 121.8 Million

2035 Market Size

$ 528.76 Million

Food, Beverages & Nutrition ● Updated August 2026 Report ID: MRFR/FnB/13837-HCR | Pages: 128 | Author: Snehal Singh

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Application (USD Million)
  1. 4.1.1 Infant Formula
  2. 4.1.2 Functional Foods
  3. 4.1.3 Dietary Supplements
2. 4.2 Medical Device, BY Source (USD Million)
  1. 4.2.1 Human Milk
  2. 4.2.2 Synthetic Production
  3. 4.2.3 Animal Milk
3. 4.3 Medical Device, BY Form (USD Million)
  1. 4.3.1 Powder
  2. 4.3.2 Liquid
  3. 4.3.3 Capsules
4. 4.4 Medical Device, BY End Use (USD Million)
  1. 4.4.1 Healthcare
  2. 4.4.2 Food and Beverages
  3. 4.4.3 Nutraceuticals
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Nestle (CH)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Danone (FR)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Bifidobacterium (DE)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 FrieslandCampina (NL)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Synlogic (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Ginkgo Bioworks (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Ferring Pharmaceuticals (CH)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Evolva (CH)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY APPLICATION
3. 6.3 US MARKET ANALYSIS BY SOURCE
4. 6.4 US MARKET ANALYSIS BY FORM
5. 6.5 US MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY APPLICATION, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY APPLICATION, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY SOURCE, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY SOURCE, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY FORM, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY FORM, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  2. 7.2.2 BY SOURCE, 2025-2035 (USD Million)
  3. 7.2.3 BY FORM, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Human Milk Oligosaccharides Market Segmentation

US Human Milk Oligosaccharides Market By Application (USD Million, 2025-2035)

Infant Formula
Functional Foods
Dietary Supplements

US Human Milk Oligosaccharides Market By Source (USD Million, 2025-2035)

Human Milk
Synthetic Production
Animal Milk

US Human Milk Oligosaccharides Market By Form (USD Million, 2025-2035)

Powder
Liquid
Capsules

US Human Milk Oligosaccharides Market By End Use (USD Million, 2025-2035)

Healthcare
Food and Beverages
Nutraceuticals

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”